当前位置: 首页 > 期刊 > 《中国当代医药》 > 2011年第21期
编号:12107787
非酒精性脂肪肝的诊治新进展
http://www.100md.com 2011年7月25日 《中国当代医药》 2011年第21期
     [6]Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a proteinsecreted by visceral fat that mimics the effects of insulin[J].Science,2005,307:426-430.

    [7]Ueno T,Sugawara H,Sujaku K,et al.Therapeutic effects ofrestricted diet and exercise in obese patients with fatty liver[J].J Hepatol,1997,27(1):103-107.

    [8]谭远忠,魏文斌.中西医结合治疗非酒精性脂肪肝的临床观察[J].湖北中医杂志,2007,29(2):25-26.

    [9]杨磊,吕瑞民.中西医结合治疗非酒精性脂肪肝70例临床观察[J].中医药学报,2008,36(5):66-67.

    [10]Bergasa NV,Mehlman J,Bir K.Aeroic exercice:a potential therapeutic intervention for patients with liver disease[J].MedHypotheses,2004,62(6):935-941.

    [11]Hasegawa T,Yoneda M,Nakmura K.Plasma tramforming growthnz factor-betal 1evel and efficacy of alphatocopherol in patients with non-alcoholic steatohepatitia s:a pilot study[J].Aliment Pharmacol ther, 2001,15:1667-1672.

    [12]Abdelmalek MF,Angulo P,Jorgensen RA.Sylvestre PB Lindor KD Betaine,a promising new agent forpatients with nonalcoholic steatohepatitis:results of a pilot study[J].Am J gastioenterol,2001,96(9):2711-2717.

    (收稿日期:2011-03-22), http://www.100md.com(刘芳)
上一页1 2